Back to top

Myriad Genetics: (MYGN)

(Market Close from NSDQ) As of Nov 21, 2014 04:00 PM ET

 Add to portfolio

 ZacksTrade Now

$32.38 USD

32.38
663,693

+0.37 (1.16%)

Volume: 663,693

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Sales 778 613 496 402 363
Cost Of Goods 109 80 65 47 44
Gross Profit 669 534 431 355 318
Selling & Adminstrative & Depr. & Amort Expenses 395 306 251 198 183
Income After Depreciation & Amortization 274 228 180 158 135
Non-Operating Income 3 5 4 2 6
Interest Expense 0 0 0 0 0
Pretax Income 278 233 185 160 141
Income Taxes 102 86 72 59 -11
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 176 147 112 101 152
Extras & Discontinued Operations 0 0 0 0 0
Net Income 176 147 112 101 152
Depreciation Footnote 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Income Before Depreciation & Amortization 288 237 189 165 142
Depreciation & Amortization (Cash Flow) 14 9 9 7 7
Income After Depreciation & Amortization 274 228 180 158 135
Earnings Per Share Data 6/30/14 6/30/13 6/30/12 6/30/11 6/30/10
Average Shares 78.18 83.33 86.47 91.70 99.15
Diluted EPS Before Non-Recurring Items 2.43 1.77 1.30 1.10 1.39
Diluted Net EPS 2.25 1.77 1.30 1.10 1.54

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Sales 168.84 188.77 182.92 204.06 202.47
Cost Of Goods 34.87 30.98 26.61 26.13 25.48
Gross Profit 133.97 157.79 156.32 177.93 176.99
SG&A, R&D, and Dept/Amort Expenses 108.05 104.54 101.03 94.93 94.08
Income After SG&A, R&D, and Dept/Amort Expenses 25.92 53.25 55.29 83.00 82.91
Non-Operating Income -0.04 -0.70 2.06 1.15 0.92
Interest Expense 0.00 0.00 0.00 0.00 0.00
Pretax Income 25.88 52.55 57.34 84.14 83.83
Income Taxes 9.90 18.92 20.57 33.78 28.36
Minority Interest 0.00 0.00 0.00 0.00 0.00
Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
Other Income/Charges 0.00 0.00 0.00 0.00 0.00
Income From Cont. Operations 15.98 33.63 36.77 50.36 55.47
Extras & Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Net Income 15.98 33.63 36.77 50.36 55.47
Earnings Per Share Data 6/30/14 3/31/14 12/31/13 9/30/13 6/30/13
Average Shares 76.09 77.68 76.37 76.83 81.80
Diluted EPS Before Non-Recurring Items 0.25 0.48 0.60 0.66 0.68
Diluted Net EPS 0.21 0.43 0.48 0.66 0.68
 

MYGN Chart by YCharts